Literature DB >> 16496194

[Ulcerative gingivostomatitis and peridontitis].

D Gaugel1, A Klein, P K Plinkert.   

Abstract

Many systemic diseases have oral and/or pharyngeal manifestations. Mucosal lesions in the upper aerodigestive tract may be caused by granulomatous inflammations, and infectious, autoimmune and neoplastic diseases before they appear systemically or otherwise. ENT specialists can play a decisive role in identifying patients with pathological mucosal changes and transfer them to dermatology, hematology, gastroenterology or maxillofacial surgery in order to assure the best possible treatment. This article presents the case of an elderly female patient with a history of necrotising severe stomatitis that turned out to be a rare B-cell lymphoma. In the second part of the article, we present a number of common and rare diseases that may be encountered in ENT practice with an overview of clinical manifestations and current diagnostic modalities.

Entities:  

Mesh:

Year:  2006        PMID: 16496194     DOI: 10.1007/s00106-006-1382-y

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  6 in total

1.  [Vesicular diseases of mouth and oropharyngeal mucosa].

Authors:  G Baier; D Zillikens
Journal:  HNO       Date:  2002-11       Impact factor: 1.284

Review 2.  Oral manifestations of systemic diseases.

Authors:  R G Long; L Hlousek; J L Doyle
Journal:  Mt Sinai J Med       Date:  1998 Oct-Nov

Review 3.  Oral manifestations of infectious diseases.

Authors:  G Laskaris
Journal:  Dent Clin North Am       Date:  1996-04

4.  Oral lesions.

Authors:  E C Hinds; J N Kent
Journal:  Am J Gastroenterol       Date:  1971-03       Impact factor: 10.864

Review 5.  Granulomatous diseases of the oral tissues: differential diagnosis and update.

Authors:  Faizan Alawi
Journal:  Dent Clin North Am       Date:  2005-01

Review 6.  Ear-nose-throat manifestations of autoimmune rheumatic diseases.

Authors:  E D Papadimitraki; D E Kyrmizakis; I Kritikos; D T Boumpas
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.